A Chinese medicine composition for treating leukemia bone marrow transplant failure complicated by brain stem stroke after chemotherapy, wherein the composition is prepared by the following steps: (A) providing a mixture; (B) mixing the mixture with water and heating the mixture to obtain a crude extract; and (C) filtering the crude extract to remove a residue and obtain a liquid extract; wherein the mixture comprises Fructus corni, Rehmannia glutinosa, Rhizoma dioscoreae, Angelica sinensis, Cortex eucommiae, Semen cuscutae, Fructus lycii, Cinnamomum cassia, Radix aconiti lateralis preparata, Rhizoma zingiberis, Poria, Cortex phellodendri, Radix achyranthis bidentatae, and Atractylodes lancea.

A Chinese medicine composition for treating leukemia bone marrow transplant failure complicated by brain stem stroke after chemotherapy, wherein the composition is prepared by the following steps: (A) providing a mixture; (B) mixing the mixture with water and heating the mixture to obtain a crude extract; and (C) filtering the crude extract to remove a residue and obtain a liquid extract; wherein the mixture comprises Fructus corni, Rehmannia glutinosa, Rhizoma dioscoreae, Angelica sinensis, Cortex eucommiae, Semen cuscutae, Fructus lycii, Cinnamomum cassia, Radix aconiti lateralis preparata, Rhizoma zingiberis, Poria, Cortex phellodendri, Radix achyranthis bidentatae, and Atractylodes lancea.

The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.

The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.

The present invention relates to a composition for promoting the proliferation of stem cells derived from bone marrow using a palmultang extract, and more specifically, to a composition for promoting the proliferation of stem cells derived from bone marrow by administering a granulocyte colony-stimulating factor to a subject and then administering the palmultang extract to the subject. The composition of the present invention remarkably reduces side effects, such as enlargement of the spleen, which are caused by the administration of G-CSF alone for proliferation and differentiation of the stem cells, through administration in combination with the palmultang extract, thereby further promoting the proliferation and differentiation of stem cells.

The present invention wherein an oral composition contains scutellaria root and platycodon root. It is preferred that the oral composition further contains rehmannia root. In the oral composition, when a content ratio of the scutellaria root is defined as X.sub.A [mass %] and a content ratio of the platycodon root is defined as X.sub.B [mass %], it is preferred that the following relation is satisfied: 0.00005X.sub.B/X.sub.A20000.

The present invention wherein an oral composition contains scutellaria root and platycodon root. It is preferred that the oral composition further contains rehmannia root. In the oral composition, when a content ratio of the scutellaria root is defined as X.sub.A [mass %] and a content ratio of the platycodon root is defined as X.sub.B [mass %], it is preferred that the following relation is satisfied: 0.00005X.sub.B/X.sub.A20000.

A Chinese medicine composition for treating leukemia bone marrow transplant failure complicated by brain stem stroke after chemotherapy, wherein the composition is prepared by the following steps: (A) providing a mixture; (B) mixing the mixture with water and heating the mixture to obtain a crude extract; and (C) filtering the crude extract to remove a residue and obtain a liquid extract; wherein the mixture comprises Fructus corni, Rehmannia glutinosa, Rhizoma dioscoreae, Angelica sinensis, Cortex eucommiae, Semen cuscutae, Fructus lycii, Cinnamomum cassia, Radix aconiti lateralis preparata, Rhizoma zingiberis, Poria, Cortex phellodendri, Radix achyranthis bidentatae, and Atractylodes lancea.

A Chinese medicine composition for treating leukemia bone marrow transplant failure complicated by brain stem stroke after chemotherapy, wherein the composition is prepared by the following steps: (A) providing a mixture; (B) mixing the mixture with water and heating the mixture to obtain a crude extract; and (C) filtering the crude extract to remove a residue and obtain a liquid extract; wherein the mixture comprises Fructus corni, Rehmannia glutinosa, Rhizoma dioscoreae, Angelica sinensis, Cortex eucommiae, Semen cuscutae, Fructus lycii, Cinnamomum cassia, Radix aconiti lateralis preparata, Rhizoma zingiberis, Poria, Cortex phellodendri, Radix achyranthis bidentatae, and Atractylodes lancea.

Provided is a composition for treating diabetes, including a hypoglycemic agent and a Yukmijihwang-tang extract. More particularly, the hypoglycemic agent is administered into an individual, and the Yukmijihwang-tang extract is administered into the individual, thereby considerably increasing a hypoglycemic effect of the hypoglycemic agent, and preventing and reducing various diabetic complications such as diabetes and diabetic liver damage, renal damage, hyperlipidemia immunosuppression and ocular damage.